Received Mar 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3D72S | — |
patient was administered diluent for Priorix; patient was administered diluent for Priorix; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received MMR (Priorix) (batch number 3D72S, expiry date 01-SEP-2025) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: patient was administered diluent for Priorix) and inappropriate dose of vaccine administered (Verbatim: patient was administered diluent for Priorix). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 10-MAR-2025 The reporter did not know this was which dose of the Priorix vaccine. The patient was administered diluent for Priorix which led to Inappropriate dose of vaccine administered and Inappropriate preparation of medication. The healthcare professional submitted claim and stated diluent for Priorix was broken and then later confirmed only diluent was administered to a patient. This was not related to an existing case.